NLRP3 and Alzheimer disease: FMT-AD: increased the expression of NLRP3, inflammatory factors, activated microglia. FMT-AD-HP: reduced the expression of NLRP3 and neuroinflammatory factors, suppressed the activation of microglia. Con-FMT-AD: increased the expression of NLRP3 and inflammatory factors.